BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen R, Levy C, Ouldali N, Goldrey M, Béchet S, Bonacorsi S, Varon E. Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation. Clin Infect Dis 2021;72:1453-6. [PMID: 32804200 DOI: 10.1093/cid/ciaa917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Levy C, Ouldali N, Varon E, Béchet S, Bonacorsi S, Cohen R. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children. Emerg Infect Dis 2021;27:2240-1. [PMID: 34287137 DOI: 10.3201/eid2708.210037] [Reference Citation Analysis]
2 Ganaie F, Maruhn K, Li C, Porambo RJ, Elverdal PL, Abeygunwardana C, van der Linden M, Duus JØ, Sheppard CL, Nahm MH. Structural, Genetic, and Serological Elucidation of Streptococcus pneumoniae Serogroup 24 Serotypes: Discovery of a New Serotype, 24C, with a Variable Capsule Structure. J Clin Microbiol 2021;59:e0054021. [PMID: 33883183 DOI: 10.1128/JCM.00540-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Cannon K, Elder C, Young M, Scott DA, Scully IL, Baugher G, Peng Y, Jansen KU, Gruber WC, Watson W. A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination. Vaccine 2021;39:7494-502. [PMID: 34839993 DOI: 10.1016/j.vaccine.2021.10.032] [Reference Citation Analysis]
4 Senders S, Klein NP, Lamberth E, Thompson A, Drozd J, Trammel J, Peng Y, Giardina PC, Jansen KU, Gruber WC, Scott DA, Watson W. Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States. Pediatr Infect Dis J 2021;40:944-51. [PMID: 34525007 DOI: 10.1097/INF.0000000000003277] [Reference Citation Analysis]